Mutations in a Dominant-Negative Isoform Correlate with Phenotype in Inherited Cardiac Arrhythmias  by Mohammad-Panah, Raha et al.
Am. J. Hum. Genet. 64:1015–1023, 1999
1015
Mutations in a Dominant-Negative Isoform Correlate with Phenotype in
Inherited Cardiac Arrhythmias
Raha Mohammad-Panah,1,∗ Sophie Demolombe,1,∗ Nathalie Neyroud,2 Pascale Guicheney,2
Florence Kyndt,1 Maurice van den Hoff,3 Isabelle Baro´,1 and Denis Escande1
1Laboratoire de Physiopathologie et de Pharmacologie Cellulaires et Mole´culaires, INSERM CJF96-01, Hoˆpital Hotel-Dieu, Nantes, France;
2INSERM U153, Groupe Hospitalier Pitie´-Salepe´trie`re, Institut de Myologie, Paris; and 3Department of Anatomy and Embryology, Academic
Medical Center, University of Amsterdam, Amsterdam
Summary
The long QT syndrome is characterized by prolonged
cardiac repolarization and a high risk of sudden death.
Mutations in the KCNQ1 gene, which encodes the car-
diac KvLQT1 potassium ion (K) channel, cause both
the autosomal dominant Romano-Ward (RW) syndrome
and the recessive Jervell and Lange-Nielsen (JLN) syn-
drome. JLN presents with cardiac arrhythmias and con-
genital deafness, and heterozygous carriers of JLN mu-
tations exhibit a very mild cardiac phenotype. Despite
the phenotypic differences between heterozygotes with
RW and those with JLN mutations, both classes of var-
iant protein fail to produce K currents in cultured cells.
We have shown that an N-terminus-truncated KvLQT1
isoform endogenously expressed in the human heart ex-
erts strong dominant-negative effects on the full-length
KvLQT1 protein. Because RW and JLN mutations con-
cern both truncated and full-length KvLQT1 isoforms,
we investigated whether RW or JLN mutations would
have different impacts on the dominant-negative prop-
erties of the truncated KvLQT1 splice variant. In amam-
malian expression system, we found that JLN, but not
RW, mutations suppress the dominant-negative effects
of the truncated KvLQT1. Thus, in JLN heterozygous
carriers, the full-length KvLQT1 protein encoded by the
unaffected allele should not be subject to the negative
influence of the mutated truncated isoform, leaving some
cardiac K current available for repolarization. This is
the first report of a genetic disease in which the impact
of a mutation on a dominant-negative isoform correlates
with the phenotype.
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Introduction
Mutations in the KCNQ1 gene are the most frequent
cause of the autosomal dominant Romano-Ward (RW)
syndrome (MIM 192500), which is characterized by
prolonged cardiac repolarization, cardiac arrhythmias,
and a high risk of sudden death (Roden et al. 1996; Li
et al. 1998). KCNQ1 encodes a pore-forming potassium
ion (K) channel subunit termed “KvLQT1” (Wang et
al. 1996), which, in association with its regulatory b-
subunit IsK, produces the slow component of the de-
layed-rectifier cardiac K current (Barhanin et al. 1996;
Sanguinetti et al. 1996). Reduction in K current in the
heart of a patient with RW prolongs repolarization and
provokes arrhythmias.
Biallelic KCNQ1 mutations cause the Jervell and
Lange-Nielsen (JLN) syndrome (MIM 220400), in
which inherited cardiac arrhythmias are associated with
congenital deafness because of abnormal homeostasis of
the inner ear endolymph (Neyroud et al. 1997; Tyson
et al. 1997; Duggal et al. 1998). However, in contrast
with patients who have true RW, heterozygous carriers
of JLN mutations exhibit a very mild or even normal
cardiac phenotype (Fraser et al. 1964; Neyroud et al.
1997, 1998; Schulze-Bahr et al. 1997). Thus, hetero-
zygous RW and JLN mutations of the KCNQ1 gene
provoke very different cardiac phenotypes, although ex-
pression of either RW or JLN K channel mutants usu-
ally produces no K current (Chouabe et al. 1997; Shal-
aby et al. 1997).
We (Demolombe et al. 1998) and others (Jiang et
al. 1997) have shown that an N-terminus truncated
KvLQT1 splice variant (isoform 2) constitutively ex-
pressed in the human heart exerts strong dominant-neg-
ative effects on the full-length KvLQT1 protein (isoform
1). Here we demonstrate that JLN, but not RW, muta-
tions suppress dominant-negative effects of the truncated
KvLQT1, thereby explaining the different phenotypes
found in RW and JLN mutation heterozygous carriers.
This is the first report of a genetic disease in which the
impact of a mutation on a dominant-negative isoform
directs the phenotype.
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Material and Methods
KvLQT1 Plasmids
Experiments were conducted with the human
KvLQT1–isoform 1 clone identified by Chouabe et al.
(1997) (Genbank accession number AF000571). Mu-
tated KvLQT1–isoform 1 plasmids were prepared by
mutagenesis with the Transformer site-directed muta-
genesis kit (Clontech). Wild-type–isoform 2 cDNA sub-
cloned in pCI vector was digested with EcoRI and AflIII.
The digestion product corresponding to the 5′ end of
isoform 2 was ligated into mutated pCI-KvLQT1 iso-
form 1, which was also digested with EcoRI and AflIII.
All constructs were sequenced before expression studies.
Functional Expression
COS-7 cells (African green monkey kidney cells trans-
formed with SV40), obtained from the American Type
Culture Collection, were microinjected into the nucleus
with plasmids at day 1 after plating. Our protocol to
microinject cultured cells by means of the Eppendorf
ECET microinjector 5246 system has been reported else-
where (Mohammad-Panah et al. 1998). A Green Fluo-
rescence Protein pCI plasmid was used as an inert plas-
mid to ensure that cells were always injected with a
constant 15-mg/ml plasmid concentration. Whole-cell
currents were recorded as described elsewhere (Demo-
lombe et al. 1998; Mohammad-Panah et al. 1998). Cells
were continuously superfused with an extracellular so-
lution containing 145 mM NaCl; 4 mM KCl; 1 mM
MgCl2; 1 mM CaCl2; 5 mM HEPES; and 5 mM glucose;
with the pH adjusted to 7.4 with NaOH. Patch pipettes
with a tip resistance of 2.5–5 Q were filled with 145 mM
K-gluconate, 5 mM HEPES, 2 mM EGTA, 2 mM 1/2
Mg-gluconate (free-Mg2: 0.1), and 2 mM K2ATP, at pH
7.2 with KOH, whereas the extracellular medium used
to record K currents contained 145 mM Na-gluconate,
4 mM K-gluconate, 7 mM 1/2 Ca-gluconate (free-Ca2:
1), 4 mM 1/2 Mg-gluconate (free-Mg2: 1), 5 mM HE-
PES, and 5 mM glucose, at pH 7.2 with NaOH. Stim-
ulation, data recording, and analysis were performed
through an A/D converter (Labmaster). A microperfu-
sion system allowed local application and rapid change
of the different experimental solutions warmed at 37C.
Patch-clamp measurements are presented as the mean
 SEM.
KvLQT1 Mutation Carriers
All KCNQ1 mutations reported here have been de-
scribed elsewhere (Donger et al. 1997; Neyroud et al.
1997, 1998), with the exception of R243H. The R243H
mutation has been identified in a nonconsanguineous
French JLN family. The proband is a 44-year-old deaf
woman who carries the R243H mutation and another
still undetermined KvLQT1 mutation. She has a cor-
rected QT interval (QTc) of 498 ms and has experienced
several syncopes since the age of 2 years. The R243H
mutation has also been detected at the heterozygous state
in her father and her aunt, who are both asymptomatic
(QTc  434 ms and 467 ms, respectively).
Results
Functional Expression of Mutated Isoform 1 KvLQT1
Human KvLQT1–isoform 1 cDNA plasmids com-
prising either RW (R555C, Y315S, G314S) or JLN
(R243H, W305S, D544; see fig.1a) mutations were coin-
jected together with a human IsK cDNA plasmid, into
the nucleus of COS-7 cells. Twenty-four hours after in-
jection, the cells were analyzed for K channel expres-
sion. As reported elsewhere (Chouabe et al. 1997), all
the RW- or JLN-mutated constructs, except for R555C-
KvLQT1 isoform 1 (an RW mutation) and R243H-
KvLQT1 isoform 1 (a novel JLN mutation), failed to
induce detectable K current.
R555C-KvLQT1 isoform 1 produced a K current
with a reduced amplitude (tail current at 40 mV elic-
ited by a test pulse to 60 mV for 3 s: 2.03  0.89
pA/pF versus 10.86  0.97 pA/pF with wild-type iso-
form 1; n  6 and 14 cells, respectively; P ! .001) and
a strong shift in the activation curve (half-maximal po-
tential 40.7  4.3 mV; n  6; fig. 1b) when compared
to wild-type isoform 1 (0.5  1.6 mV; n  8 cells).
R243H-KvLQT1 isoform 1 produced a very small K
current (tail current at 40 mV: 0.35  0.27 pA/pF; n
 6 cells) also with a shift in the activation voltage (half-
maximal potential at around 20 mV). Thus, on the
basis of isoform 1 expression alone, RW mutations such
as Y315S or G314S, which induce a severe phenotype
in heterozygous carriers (Donger et al. 1997), cannot be
distinguished from JLN mutations such as W305S or
D544, which induce a mild phenotype in heterozygous
carriers (Neyroud et al. 1997, 1998). Furthermore, the
RW mutation R555C, which led to a sizable K current,
still induces a more-severe cardiac phenotype in hetero-
zygous carriers (Donger et al. 1997) than does JLN
mutations.
Functional Expression of Mutated Isoform 2
We next explored whether RW and JLN mutations,
which are all situated in exons common to isoforms 1
and 2, would also affect the dominant-negative activity
of isoform 2. Because the RW syndrome is inherited as
an autosomal dominant trait, affected individuals pos-
sess one normal and one mutant KCNQ1 allele. In the
hearts of affected patients, the delayed rectifier K cur-
rent available for repolarization therefore results from
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Figure 1 Expression of RW- and JLN-mutated KvLQT1 isoform 1. Schematic representation of KvLQT1 isoform 1 and isoform 2 proteins.
a, Two amino acids shown in gray are specific for isoform 2. The mutated amino acids are shown in black. The JLN mutation D544 (D544,
78) is a deletion-insertion leading to a modification of the following 107 amino acid sequence and to a premature stop codon at position
651 (Neyroud et al. 1997). Superimposed whole-cell currents in COS-7 cells injected with wild-type (WT) isoform 1 cDNA and with RW- and
JLN-mutated isoform 1 cDNA. b, Voltage steps applied in sequence from 80 mV to various voltages in the range of 100 to 60 mV, and
then to 40 mV where tail currents were recorded. Current scale: 10 pA/pF; time scale: 500 ms. Injected pCI-KvLQT1 isoform 1, pCI-IsK and
pCI-GFP plasmid concentrations: 5 mg/ml.
the association between (1) mutated isoform 1, which
produces no current (with the exception of R555C and
R243H); (2) wild-type isoform 1; (3) mutated isoform
2; (4) wild-type isoform 2; and (5) IsK proteins. We thus
investigated the dominant-negative properties of mu-
tated isoform 2 constructs on the current produced by
wild-type–isoform 1 expression. We have shown that
isoform 2 dominant-negative properties are more pro-
nounced in the absence than in the presence of IsK (De-
molombe et al. 1998). A first set of experiments was
thus conducted in the absence of IsK to exacerbate the
potential effects of a mutation on isoform 2 dominant-
negative properties. An isoform 2/isoform 1 ratio of 2/
5 was used, corresponding to the expression ratio found
in the adult human heart (Demolombe et al. 1998). As
shown in figure 2, coinjection of wild-type isoform 2
markedly reduced the K current amplitude related to
wild-type–isoform 1 expression. RW-mutated isoform 2
still exerted strong dominant-negative effects. By con-
trast, JLN mutations abolished the dominant-negative
properties of isoform 2.
As visible on current traces shown in figure 3, IsK
expression (5 mg/ml) markedly slowed the activation ki-
netics of KvLQT1 K current. In the presence of IsK (fig.
3), all RW mutations, but not JLN mutations, abolished
the functional negative effects of isoform 2. The effects
of wild-type isoform 2 were not restricted to a strong
reduction in the amplitude of the K current. Indeed,
wild-type isoform 2 also shifted to more depolarized
potential the activation curve of the KvLQT1 current
(not illustrated, but see Demolombe et al. 1998). A shift
in the activation curve was also produced by isoform 2
comprising RW mutations such as R555C and G314S,
and to a lesser extent, Y315S. By contrast, expression
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Figure 2 Expression of RW- and JLN-mutated KvLQT1 isoform 2 in the absence of IsK. a, K currents recorded in COS-7 cells injected
with wild-type (WT) isoform 1 (5 mg/ml) in the absence or presence of various isoform 2 constructs (2 mg/ml). Upper panel, Representative
current tracings in cells injected with wild-type isoform 1 alone (isoform 1) and with wild-type isoform 1 plus wild-type isoform 2 ( WT -
iso 2) cDNA. Middle panel, Currents recorded with wild-type isoform 1 plus mutated RW (G314S, Y315S, R555C) isoform 2 cDNA. Lower
panel, Currents recorded with wild-type isoform 1 plus mutated JLN (R243H, W305S, D544) isoform 2 cDNA. Voltage steps applied in sequence
from 80 mV to various voltages in the range of 100 to 60 mV, and then to 40 mV where tail currents were recorded. Pulse duration
was 1,000 ms. Current scale: 10 pA/pF; time scale: 500 ms. b, Averaged tail current amplitude in cells injected with isoform 1 (5 mg/ml) in the
absence (iso 1) and presence of wild-type (WT) or mutated RW (G314S, Y315S, R555C; dark gray bars) and JLN (R243H, W305S, D544;
light gray bars) isoform 2 plasmids (2 mg/ml). Numbers between brackets indicate the number of cells tested. NS  nonsignificant; * P ! .05;
** P ! .01 with standard t-test. In all experiments, injected plasmid concentration maintained constant at 15 mg/ml with pCI-GFP.
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Figure 3 Expression of RW- and JLN-mutated KvLQT1 isoform 2 in the presence of IsK. a, K currents recorded in COS-7 cells injected
with wild-type (WT) isoform 1 (5 mg/ml) in the absence or presence of various isoform 2 constructs (2 mg/ml). Upper panel, Representative
current tracings in cells injected with wild-type isoform 1 alone (isoform 1) and with wild-type isoform 1 plus wild-type isoform 2 ( WT -
iso 2) cDNA. Middle panel, Currents recorded with wild-type isoform 1 plus mutated RW (G314S, Y315S, R555C) isoform 2 cDNA. Lower
panel, Currents recorded with wild-type isoform 1 plus mutated JLN (R243H, W305S, D544) isoform 2 cDNA. Voltage steps applied in sequence
from 80 mV to various voltages in the range of 100 to 60 mV, and then to 40 mV where tail currents were recorded. Pulse duration
was 3,000 ms. Current scale: 10 pA/pF; time scale: 500 ms. b, Averaged tail current amplitude in cells injected with isoform 1 (5 mg/ml) in the
absence (iso 1) and presence of wild-type (WT) or mutated RW (G314S, Y315S, R555C) and JLN (R243H, W305S, D544) isoform 2 plasmids
(2 mg/ml). Numbers between brackets indicate the number of cells tested. NS  nonsignificant; * P ! .05 with standard t-test. c, Averaged tail
current amplitude in cells coinjected with a plasmid combination made of wild-type isoform 1 (2.5 mg/ml), RW- or JLN-mutated isoform 1 (2.5
mg/ml), wild-type isoform 2 (1 mg/ml), and mutated RW or JLN isoform 2 (1 mg/ml). The open bar (WT) indicates current amplitude in cells
injected with 5 mg/ml wild-type isoform 1 plus 2 mg/ml wild-type isoform 2. The dark gray bars indicate RW-mutated constructs, whereas the
light gray bars indicate JLN-mutated constructs. Differences in the tail current amplitude between WT and RW- or JLN-mutated constructs or
between RW and JLN constructs reached significance, with P ! .01. In a, b, and c, all cells were coinjected with pCI-IsK (5 mg/ml). Injected
plasmid concentration maintained constant at 15 mg/ml with pCI-GFP.
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of JLN-mutated isoform 2 did not shift the half-maxi-
mum activation potential. Expression of mutated JLN
isoform 2 slowed the deactivation kinetics of the
KvLQT1 current: deactivation time constant increased
from 63.6  15.1 ms in control to 108.7  12.0 ms
or 111.2  12.8 ms in the presence of W305S isoform
2 or D544 isoform 2, respectively (P ! .05 in both cases).
These latter findings suggest that the JLN-mutated pro-
teins were processed to the cell membrane.
Coexpression of Mutated and Wild-Type Isoforms
Finally, COS-7 cells were coinjected with a plasmid
combination mimicking the KvLQT1 cDNA composi-
tion in heterozygous carriers. This combination was
made of wild-type and mutated isoform 1 (each at 2.5
mg/ml), and wild-type and mutated isoform 2 (each at
1 mg/ml) cDNAs in the presence of IsK cDNA (5 mg/ml).
As illustrated in figure 3c, cells injected with RW-mu-
tated cDNAs produced a very small K current, whereas
cells injected with JLN-mutated cDNAs produced a siz-
able K current with a reduced amplitude, as compared
to control.
Discussion
In the normal heart, the amplitude of the delayed rec-
tifier K current available for repolarization depends on
the relative expression of KvLQT1 isoform 1 and 2 en-
coded by both alleles (fig. 4). In the absence of the reg-
ulatory b-subunit IsK, the dominant-negative effects pro-
duced by isoform 2 are strong, and almost no current
results from the expression of a physiological ratio iso-
form 2/isoform 1 (see fig. 2). In the presence of IsK, as
in the adult human heart, the dominant-negative effects
produced by isoform 2 are markedly reduced, and large
K currents can be recorded in expression system. In
heterozygous carriers of KCNQ1 mutations, the severity
of the phenotype results from a complex interplay be-
tween wild-type and mutated proteins produced by the
unaffected and affected allele, respectively (fig. 4). We
show that RW and JLN mutations cannot be function-
ally discriminated on the basis of KvLQT1–isoform 1
(the channel pore) monomer expression, since both RW
and JLN mutations abolish or strongly reduce the K
current amplitude related to isoform 1 expression. This
is in agreement with findings by others (Chouabe et al.
1997; Shalaby et al. 1997; Wollnik et al. 1997). Here,
we also show that JLN, but not RW, mutations suppress
the dominant-negative properties of KvLQT1 isoform 2.
Therefore, in cardiac cells from RW heterozygous car-
riers, wild-type KvLQT1 isoform 1 encoded by the un-
affected allele should undergo not only the dominant-
negative effects of wild-type isoform 2, but also those
of mutated isoform 2 (fig. 4). Therefore, the cardiac cells
from RW patients should express almost no delayed rec-
tifier K current (see fig. 3c). In contrast, in cardiac cells
from JLN heterozygous carriers, the K current carried
by wild-type isoform 1 from the unaffected allele should
undergo the dominant-negative effects of wild-type iso-
form 2 only, leaving a consistent current available for
repolarization (see fig. 3c). This may explain the almost
normal phenotype observed in JLN heterozygous car-
riers: in the families where the JLN mutations reported
here were identified, all heterozygous carriers were
asymptomatic, and their average corrected QT duration
was 430  34 ms (n  16); that is, below the normal
value (Denjoy I, personal communication). Furthermore,
it has been shown that RW-, but not JLN-mutated,
KvLQT1 isoform 1 exerts by itself dominant-negative
effects on wild-type KvLQT1 isoform 1 (Chouabe et al.
1997; Shalaby et al. 1997; Wollnik et al. 1997). The
novel R243H JLN mutation reported herein also pro-
duced no dominant-negative effects on wild-type iso-
form 1 (current tail at 40 mV: 10.13  3.13 pA/pF;
i.e., not different from control). This should also help
to reduce the K current in RW heterozygotes. However,
the dominant-negative effects of RW-mutated isoform 1
are weaker (coexpression of wild-type and mutated iso-
form 1 with a 1/1 ratio reduced the current by only 50%:
see Chouabe et al. 1997) than that of wild-type or RW-
mutated isoform 2 (coexpression of wild-type isoform
1 and wild-type or RW-mutated isoform 2 with a 1/0.4
ratio reduced the current amplitude by ∼90%). We thus
propose that the amplitude of the KvLQT1 current re-
maining in heterozygous carriers depends mostly on
whether or not mutated isoform 2 retains dominant-
negative properties. This is a novel mechanism whereby
a phenotype can be related to the functional conse-
quences of mutations on an alternatively spliced domi-
nant-negative isoform.
From a theoretical standpoint, studies in heterologous
expression systems cannot be expanded to genotype/phe-
notype correlations with in vivo phenotypes. Direct re-
cording of K currents in cardiac myocytes would be a
valuable step to fill the gap between heterologous sys-
tems and in vivo data. Although patch-clamp experi-
ments of native human cardiac myocytes have been
achieved, such studies cannot be performed in the con-
text of the long QT syndrome. Another possibility would
be to use transgenic or knock-out animals. It should be
realized, however, that the cardiac electrophysiology of
mice is very different from that of humans and that this
approach has its own limits and flaws. Finally, it is pos-
sible that the JLN mutants are expressed at a low level
or that the protein is unstable, resulting in a diminished
dominant-negative potential. This may be because of the
heterologous expression system in cells that do not nor-
mally express KvLQT1. In addition, it remains unclear
whether the JLN-mutated proteins are correctly ad-
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Figure 4 Schematic representation of the molecular basis of the effect on the potassium ion channel pore for dominant (RW) and recessive
(JLN) phenotypes, in comparison with the wild-type (WT) phenotype. See Discussion section for more detail.
dressed to the cell membrane. The slight modification in
the deactivation kinetics that we observed suggests, but
does not prove, that JLN-mutated isoform 2 was indeed
processed to the cell membrane. Specific experiments
with tagged wild-type and mutated isoform 2 are cur-
rently being performed in our laboratory to clarify this
important point.
KCNQ1 is not the only gene that generates dominant-
negative spliced variants. Other dominant-negative iso-
forms have been reported that concern, among other
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proteins, the transcription factor STAT6 (Patel et al.
1998), the human glucocorticoid receptor hGR (Oakley
et al. 1997), the vitamin D receptor (Ebihara et al. 1996),
the human growth factor hormone receptor GHR (Ross
et al.1997), the thyroid hormone receptor TR (Zhu et
al. 1997), the prolactine receptor, and the human estro-
gen receptor (Wang and Miksicek 1991). In the future,
these genes may be ascribed to a genetic disease (e.g.,
resistance to thyroid hormone disorders), and the po-
tential effects of mutations on the dominant-negative
isoforms should be evaluated.
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